PDB31 TOTAL COST REDUCTION IN TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS TREATED WITH PIOGLITAZONE (PIO) BASED THERAPIES VERSUS NON-THIAZOLIDINEDIONE (NON-TZD) BASED THERAPIES

Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64979-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)64979-0/fulltext
Title : PDB31 TOTAL COST REDUCTION IN TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS TREATED WITH PIOGLITAZONE (PIO) BASED THERAPIES VERSUS NON-THIAZOLIDINEDIONE (NON-TZD) BASED THERAPIES
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64979-0&doi=10.1016/S1098-3015(10)64979-0
First page :
Section Title :
Open access? : No
Section Order : 138
Categories :
Tags :
Regions :
ViH Article Tags :